Rheocarna(®) as an alternative therapeutic option for patients with chronic limb-threatening ischemia: A case report

Recently, a new low-density lipoprotein apheresis device (Rheocarna(®); Kaneka Corporation, Osaka, Japan), a blood purification therapy, was approved in Japan for managing chronic limb-threatening ischemia with refractory ulcers. Here, we describe a case of chronic limb-threatening ischemia that was...

Descripción completa

Detalles Bibliográficos
Autores principales: Satake, Akinori, Nakano, Yusuke, Niwa, Toru, Ando, Hirohiko, Takashima, Hiroaki, Amano, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850122/
https://www.ncbi.nlm.nih.gov/pubmed/36686205
http://dx.doi.org/10.1177/2050313X221149359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850122/
https://www.ncbi.nlm.nih.gov/pubmed/36686205
http://dx.doi.org/10.1177/2050313X221149359

Ejemplares similares